Site Accessibility Features: Skip to page menus


Reset Website Accessibility

Site Menus Section Skip to page content

Dec 05 2024

A Breakthrough in Feline Diabetes Care: SGLT2 Inhibitors

Home » News » A Breakthrough In Feline Diabetes Care Sglt2 Inhibitors

Managing diabetes in cats has traditionally relied on insulin injections and diet adjustments. However, a new class of oral medication called Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors is changing how veterinarians approach treatment for newly diagnosed diabetic cats. Let’s explore how these medications work, their benefits, and what cat owners should know.

What are SGLT2 inhibitors?

SGLT2 inhibitors, such as Bexagliflozin (Bexacat) and Velagliflozin, help control diabetes by encouraging the kidneys to get rid of excess glucose through urine, reducing blood sugar without relying on insulin. These medications are designed for cats that are newly diagnosed and have not yet started insulin therapy, offering a simpler treatment option for certain patients.

Unlike insulin, SGLT2 inhibitors do not carry a high risk of causing dangerously low blood sugar (hypoglycemia), making them a safer option for some cats. However, to be successful, these drugs can only be used in cats that still produce some insulin naturally, as they are not a substitute for insulin.

What are the benefits of SGLT2 inhibitors?

  1. Ease of administration: Given orally, these medications may be easier to administer than insulin injections, reducing stress for both pets and owners.
  2. Effective glucose control: Studies show significant improvements in blood sugar levels and related clinical signs, such as excessive thirst, urination, and weight loss. Some cats may even achieve diabetic remission.
  3. Improved quality of life: Because these medications are easier to give than injections, it’s more likely you will adhere to the treatment plan, which means better quality of life for your cat.

Potential Risks and Considerations

While SGLT2 inhibitors offer promise, they are not suitable for every cat. Potential side effects include:

What Cat Owners Should Know

The Future of Feline Diabetes Care

The introduction of SGLT2 inhibitors is a significant advancement in treating feline diabetes. These medications provide an effective and convenient option for newly diagnosed cats, especially when managed under close veterinary supervision. For pet owners, it’s a step forward in making diabetes management less daunting and more accessible.

For more details, consult your veterinarian.

LifeLearn News

Note: This article, written by LifeLearn Animal Health (LifeLearn Inc.) is licensed to this practice for the personal use of our clients. Any copying, printing or further distribution is prohibited without the express written permission of Lifelearn. Please note that the news information presented here is NOT a substitute for a proper consultation and/or clinical examination of your pet by a veterinarian.

Have a Question? Need to book an appointment?

Connect with us and one of our team members will be happy to assist you.
Contact

P:(860) 642-7936 E: lebanonvethospital@gmail.com

Location

920 Trumbull Hwy Lebanon, CT 06249

Hours

Mon: 8:30 am 8:00 pm Tues: 8:00 am 8:00 pm Wed: 8:30 am 5:00 pm Thurs: 8:00 am 8:00 pm Fri: 8:30 am 5:00 pm

Saturdays: 8:30 am 1:00 pm Sundays: Closed

Emergency Information

Our doctors want to help in any way they can. We see Urgent/Emergency cases until 8:00 pm most nights and are growing and expanding to offer more nights! If you call the office and we are already closed, please contact one of the hospitals recommended in the message.

Urgent Care is every day by appointment. Please call.

© 2025 Lebanon Veterinary Hospital. Powered by LifeLearn Veterinary Websites